Here is the latest stock price and chart of ADESHWAR MEDITEX. For more details, see the ADESHWAR MEDITEX company fact sheet and quarterly results. For a sector overview, read our pharmaceuticals sector report.
Revealing Soon: A Potential Huge Investing Opportunity for Investors
Live BSE Quotes | May 15, 2024 (Close) | ||
---|---|---|---|
Price (Rs)29.45 | Open (Rs) 29.98 | High (Rs) 29.98 | Low (Rs) 29.45 |
% Change6.32 | Volume 12,000 | Value (Rs) 356,580 | 52-Week H/L 36.00 / 18.30 |
Live NSE Quotes |
---|
Not listed |
Change | |||||
---|---|---|---|---|---|
Valuation | ||||
---|---|---|---|---|
EPS (Rs)* - | P/E Ratio (x) - | Market Cap (Rs m) 425.00 | P/BV (x) 1.29 | Dividend Yield (%) 0.00 |
*Trailing 12 months earnings, excluding extraordinary / exceptional items. | BSE Sensex | CNX Nifty |
S&P BSE SENSEX
|
||||||
PERIOD |
As of March 2024, company promoters held 42.65% stake in , with no shares having been pledged. To know more, check out the latest shareholding pattern of .
The last traded price of ADESHWAR MEDITEX was Rs 29.5 on the BSE, up 6.3% over the previous close.
The current market capitalisation of ADESHWAR MEDITEX stands at Rs 425 m.
Based on marketcap, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks ranked by marketcap here.
Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.
Based on sales, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.
Based on net profit, these are the top pharmaceuticals companies in India:
You can see the full list of pharmaceuticals stocks.
In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.
After opening the day on positive note, Indian share markets continued the momentum as the session progressed and ended on firm footing.